17-30832386-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_024857.5(ATAD5):āc.39G>Cā(p.Pro13=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 1,558,698 control chromosomes in the GnomAD database, including 22,406 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.23 ( 6144 hom., cov: 32)
Exomes š: 0.13 ( 16262 hom. )
Consequence
ATAD5
NM_024857.5 synonymous
NM_024857.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0680
Genes affected
ATAD5 (HGNC:25752): (ATPase family AAA domain containing 5) Enables DNA clamp unloader activity. Involved in DNA clamp unloading; positive regulation of DNA replication; and positive regulation of cell cycle G2/M phase transition. Part of Elg1 RFC-like complex. Biomarker of neurilemmoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 17-30832386-G-C is Benign according to our data. Variant chr17-30832386-G-C is described in ClinVar as [Benign]. Clinvar id is 3059114.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.068 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.482 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATAD5 | NM_024857.5 | c.39G>C | p.Pro13= | synonymous_variant | 1/23 | ENST00000321990.5 | NP_079133.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATAD5 | ENST00000321990.5 | c.39G>C | p.Pro13= | synonymous_variant | 1/23 | 1 | NM_024857.5 | ENSP00000313171 | P1 | |
ATAD5 | ENST00000578295.5 | c.39G>C | p.Pro13= | synonymous_variant | 1/15 | 1 | ENSP00000463102 |
Frequencies
GnomAD3 genomes AF: 0.231 AC: 35025AN: 151892Hom.: 6107 Cov.: 32
GnomAD3 genomes
AF:
AC:
35025
AN:
151892
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.162 AC: 34700AN: 213678Hom.: 3968 AF XY: 0.158 AC XY: 18417AN XY: 116356
GnomAD3 exomes
AF:
AC:
34700
AN:
213678
Hom.:
AF XY:
AC XY:
18417
AN XY:
116356
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.133 AC: 187322AN: 1406688Hom.: 16262 Cov.: 31 AF XY: 0.135 AC XY: 94609AN XY: 699186
GnomAD4 exome
AF:
AC:
187322
AN:
1406688
Hom.:
Cov.:
31
AF XY:
AC XY:
94609
AN XY:
699186
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.231 AC: 35125AN: 152010Hom.: 6144 Cov.: 32 AF XY: 0.229 AC XY: 17022AN XY: 74314
GnomAD4 genome
AF:
AC:
35125
AN:
152010
Hom.:
Cov.:
32
AF XY:
AC XY:
17022
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
813
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ATAD5-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at